72.93% Tumor Inhibition Seen in Dual-Drug Nanoparticle Mouse Study
Can nanotechnology reduce breast cancer drug side effects? This preclinical study found a dual-drug nanoparticle system cut tumor growth by 72.93% in mice.
One Drug at a Time May Be Why Immunotherapy Falls Short
This review explains the science behind cold tumor hot tumor immunotherapy how to switch, focusing on how nanocarrier delivery may reshape treatment precision in ongoing research.
Stressed Cancer Cell Batteries Leak Signals That Mimic a Virus
This review paper examines how cold tumor biology and mitochondrial stress connect, exploring what the cGAS-STING pathway reveals about cold tumor how to make immunotherapy work.
TAM Center Reviews How Precision Cell Selection Could Sharpen MSC Therapies
Are all stem cell treatments the same? This review covers how MSC subpopulations defined by specific markers may explain inconsistent results seen across cell therapy trials.